v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash $ 51,571,540 $ 7,908,181
Accounts receivable 560,429 216,504
Inventory 84,851 0
Receivable from noncontrolling interests 0 721,548
Prepaid expenses and other current assets 3,872,444 1,664,023
Total current assets 56,089,264 10,510,256
Property and equipment, net 22,984,292 10,712,839
Operating lease right-of-use assets, net 1,360,829 1,258,701
Goodwill 3,461,459 3,267,103
Other noncurrent assets 229,899 1,793,014
Total assets 84,125,743 27,541,913
Current liabilities:    
Accounts payable 1,797,536 1,111,819
Accrued expenses 1,762,422 1,311,245
Notes payable 33,446 470,396
Finance lease liabilities - current 695,235 61,941
Operating lease liabilities - current 589,457 336,564
Deferred revenue 882,000 882,000
Other current liabilities 1,249,249 1,500,000
Share liability 416,652 0
Total current liabilities 7,425,997 5,673,965
Deferred tax liabilities 83,867 110,578
Convertible notes payable, at fair value 31,778,742 0
Finance lease liabilities - noncurrent 1,913,143 207,092
Operating lease liabilities - noncurrent 912,519 1,066,647
Other noncurrent liabilities 0 1,653,000
Total liabilities 42,114,268 8,711,282
Commitments and contingencies (Note 8)
Stockholders' equity    
Preferred stock, $0.01 par value; 10,000,000 shares authorized, no shares issued and outstanding as of September 30, 2024 and December 31, 2023 0 0
Common stock, $0.01 par value; 500,000,000 shares authorized, 68,409,116 and 48,923,276 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively 684,092 489,233
Additional paid-in capital 84,406,759 40,567,003
Accumulated deficit (46,991,549) (23,839,300)
Accumulated other comprehensive income (loss) 595,735 (920,982)
Total ASP Isotopes stockholders' equity 38,695,037 16,295,954
Noncontrolling interests 3,316,438 2,534,677
Total stockholders' equity 42,011,475 18,830,631
Total liabilities and stockholders' equity $ 84,125,743 $ 27,541,913

Source

HTML PDF
ZIP